arrow
S

Shunsuke Kita

hokkaido university
H指数:16
被引数:1,064

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions

生物安全三级条件下活动性严重急性呼吸综合征冠状病毒2的冷冻电子断层扫描

2026-11-050
OAAI
Lipidated macrocyclic peptide S-880008 inhibits SARS-CoV-2 fusion by suppressing protomer dissociation at conserved spike sites

脂质化大环肽S-880008通过抑制保守刺突位点的原聚体解离来抑制SARS-CoV-2融合

2026-10-280
OAAI
Molecular basis for selection and inhibition of HIV-1 escape virus by T cells and KIR2DL2+NK cells

T细胞和KIR2DL2+NK细胞对HIV-1逃逸病毒的筛选与抑制的分子基础

2025-11-060
OAAI
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction
2025-04-010
OAAI
Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants
2025-03-220
OAAI
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
2024-02-0827
OAAI
2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses
2023-10-135
OAAI
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
2023-07-1410
OAAI
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
2023-05-16150
OAAI
Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants

新型超中和抗体UT28K能够保护免受多种SARS-CoV-2变体的感染

MABS
IF7.3
2022-05-117
OAAI
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
IMMUNITY
IF26.3
2021-10-0133
OAAI